Abstract
Mycotic abdominal aortic aneurysms (AAAs) are a clinical challenge for vascular surgeons due to their critical location, surrounding inflammation, risk of rupture, and danger of reinfection following treatment. We present a case of Mycobacterium bovis AAA in a 69-year-old male after treatment with intravesicular bacillus Calmette-Guérin (BCG) therapy for bladder carcinoma. The classical approach for mycotic AAA entails extra-anatomic reconstruction followed by resection with oversewing of the proximal and distal aortic stumps. Alternative in-line reconstruction options have also been advocated. This case illustrates a technically straightforward, durable, in-line repair within an infected field utilizing cryopreserved aortic allograft.
MeSH terms
-
Administration, Intravesical
-
Aged
-
Aneurysm, Infected / diagnosis
-
Aneurysm, Infected / microbiology
-
Aneurysm, Infected / surgery*
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / adverse effects*
-
Aortic Aneurysm, Abdominal / diagnosis
-
Aortic Aneurysm, Abdominal / microbiology
-
Aortic Aneurysm, Abdominal / surgery*
-
Aortography / methods
-
BCG Vaccine / administration & dosage
-
BCG Vaccine / adverse effects*
-
Bioprosthesis*
-
Blood Vessel Prosthesis Implantation / instrumentation*
-
Blood Vessel Prosthesis*
-
Cryopreservation*
-
Humans
-
Male
-
Mycobacterium bovis / isolation & purification*
-
Plastic Surgery Procedures*
-
Prosthesis Design
-
Tomography, X-Ray Computed
-
Treatment Outcome
-
Tuberculosis, Cardiovascular / diagnosis
-
Tuberculosis, Cardiovascular / microbiology
-
Tuberculosis, Cardiovascular / surgery*
-
Urinary Bladder Neoplasms / drug therapy*
Substances
-
Antineoplastic Agents
-
BCG Vaccine